FDA approves Pfizer's treatment for certain lung cancer patients
FILE PHOTO: A man walks past Pfizer’s world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo (Reuters) – Pfizer Inc said on Friday the U.S. Food and Drug Administration has approved its lung-cancer treatment for patients with a specific gene mutation who had been previously treated for an aggressive form of the disease.… Read More »